BLOG

Pharma's Almanac

Uncovering New Drug Targets for Neurological Diseases

Cerevance has developed its proprietary, Nuclear Enriched Transcript Sort sequencing (NETSseq) platform to analyze postmortem human brain tissues to produce rich cell type–specific data sets.